These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10095921)

  • 1. [Effectiveness of acipole in prevention of enteric dysbacteriosis due to antibacterial therapy].
    Oleĭnichenko EV; Mitrokhin SD; Nonikov VE; Minaev VI
    Antibiot Khimioter; 1999; 44(1):23-5. PubMed ID: 10095921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intestinal dysbacteriosis in yersiniosis patients and the possibility of its correction with biopreparations].
    Kuznetsov VF; Iushchuk ND; Iurko LP; Nabokova NIu
    Ter Arkh; 1994; 66(11):17-8. PubMed ID: 7900004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute pyelonephritis associated with intestinal dysbacteriosis: incidence and enhancement of efficiency of treatment].
    Ukhal' EM; Ukhal' MI
    Lik Sprava; 2000 Sep; (6):74-7. PubMed ID: 11452928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Principles of decontaminating the small intestine with bacterial preparations in experimental antibiotic dysbacteriosis].
    Martynov AI; Pinegin BV; Korshunov VM
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Apr; (4):50-6. PubMed ID: 7080760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pseudomembranous colitis and "intestinal sepsis" as a consequence of dysbacteriosis due to antibiotics].
    Eriukhin IA; Shliapnikov SA; Lebedev VF; Ivanov GA
    Vestn Khir Im I I Grek; 1997; 156(2):108-11. PubMed ID: 9235747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The principles of the combined therapy of intestinal dysbacteriosis].
    Krylov VP; Orlov VG; Malysheva TV
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (4):64-6. PubMed ID: 9783405
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness and cost-effectiveness of antibiotic treatments for community acquired pneumonia (CAP) and acute exacerbations of chronic bronchitis (AECB).
    Lavoie F; Blais L; Castilloux AM; Scalera A; LeLorier J
    Can J Clin Pharmacol; 2005; 12(2):e212-7. PubMed ID: 15998960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The efficacy of the eubiotic bifacide when used in the combined antibacterial therapy of newborn infants with infectious-inflammatory diseases].
    Kushnareva MV; Dement'eva GM; Chernonog IN; Frolova MI; Feklisova LV; Rebrova TN
    Antibiot Khimioter; 1996; 41(11):28-32. PubMed ID: 9214283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of sporulating bacteria in treating patients with dysbacteriosis].
    Voĭchishina LG; Chaplinskiĭ VIa; V'iunitskaia VA
    Vrach Delo; 1991 Dec; (12):73-5. PubMed ID: 1792782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The dysbacteriosis of extreme states].
    Liz'ko NN
    Antibiot Med Biotekhnol; 1987 Mar; 32(3):184-6. PubMed ID: 3579245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of propiono-acidophilus milk in the complex treatment of intestinal dysbacteriosis in infants with staphylococcal infections and sepsis].
    Korneva VV; Nabukhotnyĭ TK; Cherevko SA; Kravets AA; Sidorchuk II
    Vopr Pitan; 1979; (5):37-40. PubMed ID: 583187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of antibiotic-resistant Bifidobacterium biphidum and Lactobacillus acidophilus in the course of antibiotic therapy].
    Branca G; Salvaggio E; Manzara S; Paone FM
    Clin Ter; 1979 Sep; 90(6):565-78. PubMed ID: 119605
    [No Abstract]   [Full Text] [Related]  

  • 13. [The prevention and treatment of a Candida-mycosis type of dysbacteriosis in chronic bronchitis in older patients].
    Khrystych TM; Shestakova KH; Krakov'iats'ka NV
    Lik Sprava; 1999; (3):109-11. PubMed ID: 10474952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Severe forms of acute pneumonia with a protracted course accompanied by liver and intestinal dysfunction and dysbacteriosis in young children].
    Fedenko NN; Fedenko SI
    Pediatriia; 1988; (11):36-41. PubMed ID: 3226801
    [No Abstract]   [Full Text] [Related]  

  • 15. [Correction of intestinal dysbacteriosis with biological preparations in acute leukemia].
    Tolkacheva TV; Abakumov EM; Martynova VA; Golosova TV
    Probl Gematol Pereliv Krovi; 1981 Jul; 26(7):29-33. PubMed ID: 7279892
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intestinal dysbacteriosis in children].
    Iatsyk GV; Gribakin SG
    Feldsher Akush; 1988 Mar; 53(3):36-9. PubMed ID: 3378637
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intestinal dysbacteriosis in antibacterial therapy and perspectives in treatment by antibiotic-resistant probiotics].
    Lykova EA
    Antibiot Khimioter; 2001; 46(3):21-5. PubMed ID: 11548277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Microbial intestinal biocenosis in lingering and complicated course of community pneumonia].
    Osipov MIu; Bilev AE; Osipov IuA
    Ter Arkh; 2008; 80(2):52-7. PubMed ID: 18372597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Large intestine dysbacteriosis and therapy efficacy in patients with respiratory tract tuberculosis in sanatoria].
    Dugina NN; Chebotareva TV; Mitrokhin SD
    Antibiot Khimioter; 2004; 49(4):35-8. PubMed ID: 15460021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
    DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D
    Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.